# Biolimus A9™ (BA9™) Drug Coated Balloon (DCB) Study

Study · id `cardio:ct-nct04079192` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04079192](<https://clinicaltrials.gov/study/NCT04079192>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04079192

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 201 participants.

## Technical summary

Registry record NCT04079192. Randomized; single masking; primary purpose treatment. Start 2020-08-07 (actual); primary completion 2023-04 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 201 participants (enrolled count; ClinicalTrials.gov record NCT04079192, source copy `cardio:ctgov-nct04079192-2022-08-10`, retrieved 2026-10-26)
- Started: 2020-08-07 (actual) (ClinicalTrials.gov record NCT04079192, source copy `cardio:ctgov-nct04079192-2022-08-10`, retrieved 2026-10-26)
- Primary completion: 2023-04 (anticipated) (ClinicalTrials.gov record NCT04079192, source copy `cardio:ctgov-nct04079192-2022-08-10`, retrieved 2026-10-26)
- Completion: 2024-04 (anticipated) (ClinicalTrials.gov record NCT04079192, source copy `cardio:ctgov-nct04079192-2022-08-10`, retrieved 2026-10-26)
- Countries: Germany; Ireland; Italy; Spain; United Kingdom (ClinicalTrials.gov record NCT04079192, source copy `cardio:ctgov-nct04079192-2022-08-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04079192-2022-08-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Biolimus A9™ (BA9™) Drug Coated Balloon (DCB) Study
- Acronym: REFORM
- Condition: Coronary Artery Disease
- Condition: In-Stent Restenosis
- Intervention (Device): Biolimus A9 Drug Coated Balloon
- Intervention (Device): SeQuent Please Paclitaxel Drug Coated Balloon
- Lead sponsor: Biosensors Europe SA
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Biosensors Europe SA (`cardio:org-biosensors-europe-sa`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Randomized Trial of Biolimus DCB for In-Stent Restenosis: The Primary Results of the REFORM Study (`cardio:pubmed-39918494`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Final 2-Year Results of the REFORM Study: A Randomized Trial of Biolimus DCB Versus Paclitaxel DCB for In-Stent Restenosis (`cardio:pubmed-42605897`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 58799a37facb2a4cbcb86ea315266597e90acc703396e9c568021cbd9b8507e1
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
